Fragrances in Serbia

Fragrance products are considered by many Serbian consumers to be non-essential and people are quick to cut back on such expenses during times of economic turmoil. However, when the situation is the opposite, ie when disposable income is growing, consumers quickly start spending more on these products. This was the most important factor influencing the relatively strong growth of fragrances in Serbia during 2017.

Euromonitor Internationals Fragrances in Serbia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2013-2017, allowing you to identify the sectors driving growth. Forecasts to 2022 illustrate how the market is set to change.

Product coverage: Mass Fragrances, Premium Fragrances.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Fragrances market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the markets major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.


FRAGRANCES IN SERBIA
Euromonitor International
May 2018

LIST OF CONTENTS AND TABLES

Headlines
Prospects
Growing Disposable Income Levels Have A Direct and Immediate Positive Effect on Fragrances in Serbia
Mass Unisex Fragrances and Mass Womens Fragrances Record the Highest Value Growth in 2017
Celebrity Fragrances Become More Important
Competitive Landscape
Fragrances Has A Relatively High Level of Concentration
Private Label Remains Unavailable
Sarantis Posts the Best Performance in 2017, While Oriflame Kozmetika Doo Keeps Declining Strongly
Category Data
Table 1 Sales of Fragrances by Category: Value 2012-2017
Table 2 Sales of Fragrances by Category: % Value Growth 2012-2017
Table 3 NBO Company Shares of Fragrances: % Value 2013-2017
Table 4 LBN Brand Shares of Fragrances: % Value 2014-2017
Table 5 LBN Brand Shares of Premium Mens Fragrances: % Value 2014-2017
Table 6 LBN Brand Shares of Premium Womens Fragrances: % Value 2014-2017
Table 7 Forecast Sales of Fragrances by Category: Value 2017-2022
Table 8 Forecast Sales of Fragrances by Category: % Value Growth 2017-2022
Executive Summary
Beauty and Personal Care in Serbia Records Healthy Growth in 2017
Private Label Lines Become More Significant in Colour Cosmetics
the Leading Three Manufacturers Record Value Share Increases in 2017
New Formulas and Brand Extensions Mark New Product Launches in 2017
Stronger Growth Is Expected Over the Forecast Period
Market Data
Table 9 Sales of Beauty and Personal Care by Category: Value 2012-2017
Table 10 Sales of Beauty and Personal Care by Category: % Value Growth 2012-2017
Table 11 GBO Company Shares of Beauty and Personal Care: % Value 2013-2017
Table 12 NBO Company Shares of Beauty and Personal Care: % Value 2013-2017
Table 13 LBN Brand Shares of Beauty and Personal Care: % Value 2014-2017
Table 14 Penetration of Private Label in Beauty and Personal Care by Category: % Value 2012-2017
Table 15 Distribution of Beauty and Personal Care by Format: % Value 2012-2017
Table 16 Distribution of Beauty and Personal Care by Format and Category: % Value 2017
Table 17 Forecast Sales of Beauty and Personal Care by Category: Value 2017-2022
Table 18 Forecast Sales of Beauty and Personal Care by Category: % Value Growth 2017-2022
Sources
Summary 1 Research Sources













Parkinsons Disease - Pipeline Review, H1 2020

Parkinsons Disease - Pipeline Review, H1 2020 market research report available in single user pdf license with Aarkstore Enterprise at USD 2500

USD 2500 View Report

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2020

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2020 latest Pharmaceutical and Healthcare disease pipeline guide Kidney Cancer - Pipeline Review, H1 2020, provides an overview of the Kidney

USD 2500 View Report

Parkinsons Disease - Pipeline Review, H1 2020

Parkinsons Disease - Pipeline Review, H1 2020 market research report available in single user pdf license with Aarkstore Enterprise at USD 2500

USD 2500 View Report

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2020

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2020 latest Pharmaceutical and Healthcare disease pipeline guide Kidney Cancer - Pipeline Review, H1 2020, provides an overview of the Kidney

USD 2500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available